Trust Co. of Vermont Acquires Shares of 4,206 Cardinal Health, Inc. $CAH

Trust Co. of Vermont acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) in the second quarter, HoldingsChannel.com reports. The fund acquired 4,206 shares of the company’s stock, valued at approximately $999,000.

Other hedge funds also recently made changes to their positions in the company. University of Texas Texas AM Investment Management Co. bought a new stake in Cardinal Health in the 4th quarter worth $26,000. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health in the fourth quarter valued at about $27,000. Jones Financial Companies Lllp raised its stake in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Palladiem LLC purchased a new stake in shares of Cardinal Health during the fourth quarter worth about $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in shares of Cardinal Health during the first quarter worth about $29,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $234.85 on Wednesday. The company has a 50 day simple moving average of $231.38 and a two-hundred day simple moving average of $217.51. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30. The company has a market capitalization of $54.62 billion, a price-to-earnings ratio of 32.48, a P/E/G ratio of 1.26 and a beta of 0.49.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The firm had revenue of $63.67 billion for the quarter, compared to analysts’ expectations of $65.15 billion. During the same period in the previous year, the firm posted $2.08 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is presently 28.49%.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. William Blair started coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. lifted their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Barclays boosted their price target on shares of Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, Wells Fargo & Company increased their price objective on Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $265.93.

Check Out Our Latest Report on CAH

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.